Option Care Health, Inc. · NASDAQ:OPCH
Option Care Health — 44th Annual J.P. Morgan Healthcare Conference 2026
18 slides from Option Care Health's conference presentation, Jan 12, 2026
Slide 1: Extraordinary Care That Changes Lives
Extraordinary Care That Changes Lives © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Option Care Health, Inc. 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1
Slide 2: Disclaimers: Forward-Looking Statements
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward-Looking Statements This presentation may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be ident
Slide 3: Disclaimers: Preliminary Unaudited Financial Data
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Preliminary Unaudited Financial Data The preliminary financial information included in this presentation is subject to completion of our year-end close procedures and further financial review. We have provided ranges, rather than specif
Slide 4: Our purpose and mission
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 4 Our purpose Provide extraordinary care that changes lives. Our mission Transform healthcare by providing innovative services that improve outcomes, reduce overall costs of care and deliver hope for patients and families. 44 th Annual J.P. Morgan
Slide 5: Reflecting on '25, Looking Ahead to '26
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 5 Reflecting on ’25, Looking Ahead to ’26 Confident in Our Strategy and Execution 44 th Annual J.P. Morgan Healthcare Conference | January 2026 ’25 Highlights Delivered strong preliminary ’25 results including 13% revenue growth, 6% Adj. EBITDA gro
Slide 6: Leading Independent Provider of Home and Alternate Site Infusion Services
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Option Care Health is a Leading Independent Provider of Home and Alternate Site Infusion Services Stand-alone AIS and/or AIC2 Care Management Center1 National Scale with Local Responsiveness o Resilient full-service network that supports a broad se
Slide 7: Shifts Toward Cost-Effective Home and Alternate Site Care Models
Shifts Toward Cost-Effective Home and Alternate Site Care Models o U.S. Home Infusion industry projected to grow high single digit % annually, driven by therapy growth, cost pressures & patient preference including ‘aging in place’ trends o Fragmented provider landscape presents wide range of growth
Slide 8: 315,000+ Patients Served in 2025
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 8 315,000+ Patients Served in 2025 2.5 million+ Infusions administered in 2025 600+ Therapies served in 2025, including limited distribution drugs and pharma programs 88% 2025 revenue from Commercial payers 1 92% Overall Patient Satisfaction Durabl
Slide 9: Diversified Revenue & Gross Profit Mix Drives Sustainable Growth
Generic Branded Biosimilar Generic Branded Biosimilar © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Gross Profit Mix 9 Revenue Mix o Gross profit composed primarily of multisource generic & biosimilar therapies o Branded therapies represent ~50% of revenue but <20% of gross profit o Expanding
Slide 10: FY '25 Preliminary Results
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 44 10 th Annual J.P. Morgan Healthcare Conference | January 2026 FY ’25 Preliminary Results1 + Growth vs. PY2 o Net Revenue $5.645B to $5.655B, +13% o Adj. Diluted EPS $1.72 to $1.76, +10% o Adj. EBITDA $469M to $473M, +6% o Cash Flow from Operatio
Slide 11: '26 Guidance
’26 Guidance + Growth vs. PY1 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 44 11 th Annual J.P. Morgan Healthcare Conference | January 2026 Guidance Key Assumptions Well Positioned for Growth and Value Creation in ’26 1Growth represents ’26 midpoint of guidance compared to ’25 midpoint of una
Slide 12: Strong Record of Revenue Growth & Operating Leverage
1Represents ’25 midpoint of unaudited preliminary results range Strong Record of Revenue Growth & Operating Leverage Demonstrated Ability to Execute and Deliver on Growth Commitments $3.0B $5.7B 2020 2025 Preliminary $222M $471M 7.3% 8.3% 2020 2025 Preliminary Revenue Adj. EBITDA + Margin © 2026 OPT
Slide 13: Strategic Capital Deployment
$166M CapEx $303M M&A $715M Share Repo $1.2B deployed since ’21 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED ~$1.4B Operating Cash Flow | ’21 – Q3 ’25 Strong and consistent cash generation profile ~$700M 1.9x Liquidity1 Net Debt Leverage Ratio1 Robust balance sheet and strong liquidity positi
Slide 14: Compelling Investment Proposition
Shifts Toward Cost-Effective Home & Alternate Site Care Models National Scale with Local Responsiveness Diversified, Resilient Portfolio of Therapies & Pharma Programs Longstanding Payer Partnerships with 96% Coverage to Insured Lives Track Record of Double-Digit Growth Revenue & Adj. EBITDA Proven,
Slide 15: Contact Us
Contact Us Our Website © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED investors@optioncarehealth.com optioncarehealth.com 44 15 th Annual J.P. Morgan Healthcare Conference | January 2026
Slide 16: Reconciliation to Non-GAAP Measures
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Reconciliation to Non-GAAP Measures For historical reconciliations of non-GAAP financial measures, please see our SEC filings and other financial reports, which are available on our website at investors.optioncarehealth.com 44 16 th Annual J.P. Mor
Slide 17: Reconciliation to Non-GAAP Measures
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Reconciliation to Non-GAAP Measures For historical reconciliations of non-GAAP financial measures, please see our SEC filings and other financial reports, which are available on our website at investors.optioncarehealth.com 44 17 th Annual J.P. Mor
Slide 18: Reconciliation to Non-GAAP Measures
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Reconciliation to Non-GAAP Measures For historical reconciliations of non-GAAP financial measures, please see our SEC filings and other financial reports, which are available on our website at investors.optioncarehealth.com 44 18 th Annual J.P. Mor
Option Care Health — 44th Annual J.P. Morgan Healthcare Conference 2026 on 6ix